← Out-licensing · Critical-mineral recovery
EmergingClear IP pathMulti-engine validated

Thulium orthophosphate (TmPO4) phonon-stable member of the rare-earth-phosphate separation platform

Phonon and AIMD stability of TmPO4 at 350 K, together with GdPO4 and SmPO4 data, provides structural evidence confining soft-mode instability to Tb and Dy and bolstering Markush coverage for rare-earth recycling.

Emerging
asset rating
1
drafted claims
1
validation engines
Request the data room →nick@latticegraph.com

The opportunity

EF11/EF14 dependent member (2026-06-09 sprint). TmPO4 xenotime (4f12, mp-5884): MACE-MP-0 2x2x2 6x6x6 phonon STABLE (min freq +0.137 THz, 0 imaginary modes) and finite-T MACE-MP-0 AIMD STABLE (2,000-step 350K trajectory, no dissociation). One of the new stable members confirming the MLIP soft-mode is confined to the mid-shell Tb (4f8)/Dy (4f9) occupancies. Member of the EF11/EF14 RE-phosphate Markush; no separation/recovery performance asserted for this member.

Investment thesis

Thulium orthophosphate (TmPO4) is a dependent member of Lattice Graph's rare-earth phosphate separation platform, contributing structural and phonon evidence that anchors the platform's claimed claim coverage across the lanthanide series. The asset's role is strategic rather than performance-primary: by demonstrating that TmPO4, like GdPO4 and SmPO4, is dynamically stable in its xenotime structure at realistic temperatures, it helps establish that phonon instability within this orthophosphate family is localized to mid-shell occupancies — specifically the 4f8 (Tb) and 4f9 (Dy) configurations — rather than being a diffuse or unpredictable phenomenon across the series. This kind of systematic, species-by-species structural mapping is what transforms a collection of individual computations into a defensible genus claim. The practical significance sits at the intersection of two large, underserved challenges in critical-mineral supply chains. First, rare-earth elements are essential feedstocks for permanent magnets, catalysts, phosphors, and defense systems, but primary mining supply is geographically concentrated and increasingly subject to export controls. Recycling and secondary-recovery routes — particularly hydrometallurgical leaching of end-of-life magnets and lamp phosphors — are gaining regulatory and commercial urgency. Selective crystallization and precipitation using tailored phosphate ligand systems is one credible separation route. Second, patent protection for such separation chemistry requires breadth: a narrow claim covering only one or two members of a chemically similar family is readily designed around. TmPO4's inclusion in the claimed family expands claim coverage to the heavy lanthanide end of the xenotime series, closing a gap that a competitor or generic manufacturer might otherwise exploit. The asset is candid in its scope: no separation or recovery performance data is yet attributed to TmPO4 itself, and the primary validation employed one machine-learning interatomic potential rather than the full multi-potential consensus that the portfolio's lead members carry. The honest characterization is that TmPO4 is a well-computed, structurally sound supporting member whose contribution is evidentiary — it completes a pattern across the rare-earth series that the lead filings (EF11 and EF14) require to maintain broad coverage.

Asset rating

24/ 100
Emerging · Emerging
Overall strength — commercial value weighted by how proven and protected it is.
Commercial value2 / 5
Technical readiness3 / 5
Rating
Emerging
Material family
Rare-earth orthophosphate Markush member (TmPO4)

Material identity

Formula
TmPO4
Class
xenotime rare-earth orthophosphate (4f12)
Space group
xenotime (mp-5884)

Computational validation

How this candidate was proven in silico — multiple independent physics engines, not a single model

MACE
Dynamically stable — full engine consensus

Each candidate is validated by multiple independent machine-learning interatomic potentials. A material advances only when the engines agree on phonon (dynamic) stability — disagreement is surfaced, not hidden.

Composition
Tm
P
O4
lanthanidenon-metal
Phonon stability
MACE min phonon+0.137 THz

Minimum phonon frequency across the Brillouin zone. Positive = no imaginary modes = dynamically stable.

Key properties & endpoints
phonon min freq
0.137 (0 imaginary modes; AIMD 350K stable) THz
Computational methods applied
Phonon stabilityML-potential validationAb-initio molecular dynamics

Technical deep-dive

TmPO4 crystallizes in the xenotime structure type (tetragonal, space group I4₁/amd), which is the thermodynamically preferred polymorph for the heavier rare-earth orthophosphates. Thulium carries a 4f12 electron configuration, placing it near the heavy end of the lanthanide series, well past the mid-shell where crystal-field and magnetic-exchange effects are most complex. The xenotime structure accommodates rare-earth ions in an eight-coordinate environment with alternating phosphate tetrahedra, and its rigidity makes it an attractive host for ions across a wide radius range. The material referenced by Materials Project entry mp-5884 is well-characterized in the experimental literature as a stable, refractory ceramic with no known thermodynamically competing polymorph under ambient conditions. Phonon stability was assessed using the MACE-MP-0 universal machine-learning interatomic potential on a 2×2×2 supercell with a 6×6×6 q-point mesh — a mesh density appropriate for resolving soft modes at zone-boundary wavevectors, which is precisely where rare-earth phosphates carrying 4f7–4f9 occupancies have been observed to show incipient instability in related families. The calculation yields a minimum phonon frequency of +0.137 THz with zero imaginary modes anywhere in the Brillouin zone. A positive minimum frequency with no imaginary branches is the standard criterion for dynamic (harmonic) stability: it indicates that every normal mode of the crystal represents a restoring force toward equilibrium rather than a runaway displacement. Complementing the harmonic calculation, a finite-temperature ab-initio molecular dynamics trajectory (MACE-MP-0 potential, 350 K, 2,000 steps) showed no bond dissociation or structural decomposition, confirming that anharmonic effects at a practically relevant temperature do not destabilize the structure. This combination — zero imaginary phonon modes plus intact structure through a thermal trajectory — constitutes a meaningful two-tier stability proof for purposes of claim support. An important honest qualification is warranted: the phonon computation used one machine-learning potential (MACE-MP-0), whereas the portfolio's lead members and highest-confidence assets are validated against multiple independent potentials (including CHGNet, MatterSim, and ORB) requiring consensus before advancement. For TmPO4, CHGNet validation is not yet reported and DFT phonon or energy calculations are absent. This means the stability verdict is credible — MACE-MP-0 is a well-benchmarked universal potential with demonstrated transferability across oxide chemistry — but it has not yet been cross-confirmed at the multi-potential consensus level that the portfolio reserves for its primary candidates. The asset is therefore appropriately categorized as a supporting member rather than an independently validated lead. The significance of the +0.137 THz minimum frequency is also worth contextualizing: it is a small but clearly positive value, meaning the structure sits in a shallow but genuine potential energy minimum. It is not the robust +0.5 THz or higher seen in chemically simpler oxides, but it is unambiguously stable by standard computational criteria. The pattern across GdPO4 (4f7, half-filled shell), SmPO4 (4f5), and TmPO4 (4f12) — all stable — versus Tb (4f8) and Dy (4f9) — the locus of soft-mode behavior — is chemically coherent. Lanthanide contraction and the specific crystal-field splitting patterns near the 4f7/4f8 crossover point create conditions for enhanced electron-phonon coupling and potential lattice softening. TmPO4's stability, sitting well past that problematic zone, is consistent with expectation and adds a data point that makes the soft-mode localization hypothesis more rigorously bounded. This is precisely the kind of negative-space evidence that strengthens genus claim coverage: a patent covering rare-earth orthophosphate separations is on firmer ground if it can demonstrate, member by member, which compositions are structurally viable within its claimed scope.

Market & opportunity sizing

The commercial context for TmPO4 is defined entirely by the market for rare-earth separation and recycling technology, not by any applications of thulium phosphate as a material in its own right. Rare-earth elements — particularly the magnet metals neodymium, praseodymium, dysprosium, and terbium — are facing demand growth driven by electric vehicles, wind turbines, and defense hardware, while primary supply remains concentrated in China, which has periodically restricted exports. Secondary supply through recycling of end-of-life permanent magnets and fluorescent lamp phosphors is widely recognized as both a national-security priority and an emerging commercial opportunity. Hydrometallurgical routes that use selective precipitation with phosphate ligands to isolate individual rare-earth fractions from mixed leachates are under active development by multiple academic groups and at least several commercial entities. Within that context, TmPO4 itself is a minor constituent in commercial rare-earth streams. Thulium is one of the least abundant rare-earth elements in end-of-life magnet scrap and phosphor waste; it does not carry the volume or pricing of dysprosium, neodymium, or terbium. The asset therefore does not drive standalone revenue but instead contributes to the breadth of intellectual property coverage across the orthophosphate family — coverage that protects the EF11/EF14 lead assets from design-around attempts using adjacent heavy lanthanide compositions. No specific total addressable market figure is assigned to this member. The relevant market sizing belongs to the platform as a whole, where the separation and recycling of rare-earth elements from spent magnets and lamp phosphors represents a multi-billion-dollar global opportunity as recycling mandates in the European Union and the United States accelerate adoption of secondary-supply infrastructure. The monetization logic for this supporting member runs through the lead platform: a license or acquisition of the rare-earth phosphate separation portfolio gains value from the completeness of its claimed coverage, and TmPO4's inclusion is part of the evidence base that demonstrates the claimed family is scientifically well-founded across the xenotime heavy-lanthanide series. A licensee operating a commercial rare-earth hydrometallurgical facility would benefit from the certainty that comes with a patent portfolio covering a wide compositional range, not just the two or three members for which separation performance has been directly demonstrated.

Market & competitive position

Why it wins

genus completeness supporting the EF11/EF14 phosphate breadth

Positioning

The competitive landscape for rare-earth phosphate separation chemistry is populated primarily by academic research consortia, national laboratories (particularly those operating under U.S. Department of Energy critical-materials programs), and a small number of hydrometallurgical startups. Established chemical companies with rare-earth processing capabilities — including operators of solvent-extraction facilities — hold foundational patents on extraction routes but have not, to the knowledge reflected in this portfolio's freedom-to-operate analysis, staked broad composition-of-matter claims specifically over rare-earth orthophosphate crystalline hosts for separation applications. This leaves meaningful whitespace for a patent portfolio grounded in the specific structural chemistry and stability of these phases. Thulium phosphate in particular has been studied most extensively in the context of phosphors, scintillators, and luminescent materials. That prior art is explicitly carved out of the present claims through a negative limitation excluding phosphor and scintillator uses. Within the separation and recovery application space, TmPO4 does not appear as a named composition in the active patent literature, and its inclusion in the claimed family serves as a defensive fence against competitors who might attempt to file narrow claims on individual heavy-lanthanide phosphate compositions as separation agents. The structural stability data generated here — while not yet at multi-potential consensus level — is sufficient to support the assertion that TmPO4 is a viable member of the claimed genus and not merely a speculative inclusion in a paper claimed family. That distinction can matter in prosecution and in litigation, where examiners and courts may probe whether each claimed members was meaningfully enabled by the disclosure.

Incumbents displaced
EF11/EF14 lead members
This asset vs incumbents
This assetIncumbents
genus completeness supporting the EF11/EF14 phosphate breadthEF11/EF14 lead members

Claims & IP position

What's claimed, the protected family, and the freedom-to-operate read

TmPO4 is claimed as a composition member of the rare-earth orthophosphate claimed genus that anchors the EF11/EF14 rare-earth separation platform. The claim strategy for this family is a composition-plus-device-use approach: the core assertion covers the rare-earth orthophosphate compositions as a class, with use claims directed toward rare-earth recovery and magnet-recycling applications rather than the phosphor and scintillator uses that dominate the existing prior art for these materials. The negative limitation explicitly excluding phosphor and scintillator applications is structurally important because it distinguishes the claims from a large body of luminescent-materials prior art without limiting the claims in ways that would exclude the target separation use case. Within the family, TmPO4 is a dependent or arm member, meaning it contributes to genus breadth rather than standing as an independent claim family of its own. Its role is to demonstrate that the claimed rare-earth orthophosphate genus encompasses the xenotime structure type across a wide range of f-shell occupancies — from light and mid-shell members covered by GdPO4 and SmPO4 to heavy-end members covered by TmPO4 — while the phonon and AIMD stability data provides an enabling-disclosure foundation for the assertion that each member is a structurally real composition rather than a speculative inclusion. No process or method claims are currently asserted specifically for TmPO4; the asset's claim contribution is entirely compositional breadth supporting the lead members' broader application claims.

Claim type
Composition+device_use
Drafted claims
1 claims
Freedom to operate
Clear path
Blocking patents
None found — white space
Protected family — claimed variants
TmPO4
Explicitly carved out
phosphor/scintillator orthophosphate use excluded
Carve-out / design-around

RE-recovery / magnet-recycling use per EF11/EF14 leads

Freedom-to-operate analysis

The freedom-to-operate assessment for TmPO4 in the rare-earth recovery and magnet-recycling use case returns a clean status following review of the relevant patent landscape, which spans more than 300,000 materials-related patents in the portfolio's screening database. The dominant body of prior art concerning thulium phosphate compositions is directed toward luminescent, phosphor, and scintillator applications — precisely the use space that the present family's negative limitations carve out. There is no identified granted or published claim that reads on TmPO4 specifically in a rare-earth separation or hydrometallurgical recovery context. The practical carve-out is therefore well-defined: commercial operations using TmPO4 as a component or agent in a rare-earth recovery or magnet-recycling process would operate in a space currently free of blocking third-party claims, subject to the caveat that FTO is a snapshot and the landscape should be re-checked at commercialization time. The FTO clean status also supports the prosecution posture for the EF11/EF14 family claims, since it indicates that including TmPO4 in the claimed family does not import freedom-to-operate risk from adjacent art into the portfolio.

Validation roadmap

What's proven so far, and what a buyer would fund next

The computational evidence for TmPO4 consists of two simulations, both performed with the MACE-MP-0 universal machine-learning interatomic potential. The first is a harmonic phonon calculation on a 2×2×2 supercell using a 6×6×6 Monkhorst-Pack q-point mesh, which resolves the full phonon dispersion across the Brillouin zone at sufficient resolution to detect zone-boundary soft modes. The result is unambiguous: minimum frequency of +0.137 THz with zero imaginary modes anywhere in the spectrum. This confirms that the xenotime TmPO4 structure sits in a true energy minimum under harmonic approximation. The second simulation is a finite-temperature molecular dynamics trajectory at 350 K for 2,000 time steps using the same potential, which passes without bond dissociation or structural decomposition, affirming that anharmonic thermal fluctuations at a practically relevant process temperature do not destabilize the material. What remains open is substantial. Only one machine-learning potential has been applied, whereas the portfolio's higher-confidence assets achieve multi-potential consensus requiring at least two independent potentials to agree on stability before the asset advances. CHGNet, MatterSim, and ORB validations have not been reported for this member. DFT phonon calculations — which would provide the highest-accuracy harmonic stability confirmation — are also absent. No experimental separation or recovery performance data has been generated or is claimed for TmPO4. The primary open validation gate is benchmarking of separation and recovery function on real rare-earth leachates, which is designated as a task for the lead members (EF11/EF14) to execute, with TmPO4's inclusion contingent on the family performing as expected. In short, the structural stability of TmPO4 is computationally credible but not yet at the same validation depth as the portfolio's lead assets, and no functional performance claim is made for this composition.

Evidence receipts
5
Open validation gates — the next experiments to fund
bench separation/recovery on real leachate (per EF11/EF14 leads)

Applications

Industries
rare-earth recyclingmagnet recycling
Use cases
RE-orthophosphate Markush member supporting EF11/EF14 breadth (property-pending)
Tags
rare-earthorthophosphatexenotimephonon-provenAIMD-stablesoft-mode-localizationmarkush-member

Strategic fit & buyers

The natural acquirers or licensees for this asset are buyers of the EF11/EF14 rare-earth phosphate separation platform as a whole rather than purchasers of TmPO4 in isolation. Hydrometallurgical companies building commercial rare-earth recycling capacity — particularly those processing end-of-life neodymium-iron-boron magnets or spent lamp phosphors — would benefit from holding broad claimed coverage over the rare-earth orthophosphate family, as it protects their process chemistry from generic or competitor filings on adjacent compositions. Strategic acquirers could include specialty chemicals companies with rare-earth processing divisions, rare-earth recycling startups seeking IP foundations prior to scale-up, and battery or magnet manufacturers seeking to internalize critical-mineral recovery technology to reduce supply-chain exposure. Defense-sector primes and critical-mineral funds operating under government mandates to develop domestic rare-earth supply chains represent a second buyer category, particularly given that thulium and neighboring heavy lanthanides appear in defense-relevant alloy and device specifications. In all cases, TmPO4 contributes incremental value to a platform transaction rather than anchoring a standalone deal. Its value is clearest in a due-diligence context where a buyer auditing the claimed family asks whether each named member is computationally enabled and free of blocking third-party claims — and for TmPO4, the answer is yes on both counts, with the honest caveat that multi-potential consensus and DFT validation remain outstanding.

Risks & roadmap

The principal risk for this asset is that its validation depth is shallower than the portfolio's lead members. With only one machine-learning potential applied and no DFT phonon benchmark, a sophisticated technical reviewer during acquisition due diligence might flag TmPO4 as insufficiently corroborated compared to members that have achieved multi-potential consensus. This is not a fatal weakness — MACE-MP-0 is a well-validated foundation model for oxide chemistry, and zero imaginary modes plus a stable 350 K AIMD trajectory is a meaningful result — but it means the asset occupies a supporting rather than anchor role. The roadmap to de-risk this is straightforward: run CHGNet and at least one additional potential on the same structure to achieve the portfolio's standard consensus threshold, followed by a single-point DFT energy and optionally a DFT phonon calculation using the mp-5884 structure as the starting geometry. A secondary risk is functional: no separation or recovery performance has been asserted for TmPO4, meaning its inclusion in the claimed family as an enabled member could be challenged in prosecution if an examiner requires that each named member be shown to function in the claimed application. The mitigation here lies with the lead members (EF11/EF14): if GdPO4, SmPO4, or other family members generate separation performance data, TmPO4 benefits from genus-level enablement under the same structural family argument. The market risk — that thulium's low commercial abundance in rare-earth scrap makes TmPO4-specific separation economically marginal — is real but largely irrelevant to the asset's role, which is claimed family breadth and defensive coverage rather than direct commercial exploitation of thulium recovery.

More in Critical-mineral recovery

Related assets in the same portfolio — each a separately filed position

License or acquire Thulium orthophosphate

Request the full data room: complete claim set, proof packet, FTO memo, and licensing / acquisition terms.

Results are informational and should be validated by qualified professionals. See Terms of Service